Literature DB >> 23986545

Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010.

Fatimah S Dawood1, Sandra S Chaves, Alejandro Pérez, Arthur Reingold, James Meek, Monica M Farley, Patricia Ryan, Ruth Lynfield, Craig Morin, Joan Baumbach, Nancy M Bennett, Shelley Zansky, Ann Thomas, Mary Lou Lindegren, William Schaffner, Lyn Finelli.   

Abstract

BACKGROUND: Data on the range and severity of influenza-associated complications among children are limited. We describe the frequency and severity of complications in hospitalized children aged <18 years with seasonal influenza (during 2003-2009) and 2009 pandemic influenza A(H1N1) (during 2009-2010).
METHODS: Population-based surveillance for laboratory-confirmed influenza hospitalizations was conducted among 5.3 million children in 10 states. Complications were identified by International Classification of Diseases, Ninth Revision (ICD-9) codes in medical records.
RESULTS: During 2003-2010, 7293 children hospitalized with influenza were identified, of whom 6769 (93%) had complete ICD-9 code data. Among the 6769 children, the median length of hospitalization was 3 days (interquartile range, 2-4 days), 975 (14%) required intensive care, 359 (5%) had respiratory failure, and 40 (1%) died. The most common complications were pneumonia (in 28% of children), asthma exacerbations (in 22% [793/3616] aged ≥ 2 years), and dehydration (in 21%). Lung abscess/empyema, tracheitis, encephalopathy, bacteremia/sepsis, acute renal failure, and myocarditis were rare (each ≤ 2% of children) but associated with a median hospitalization duration of ≥ 6 days, and 48%-70% of children required intensive care. Bacterial cultures with positive results were identified in 2% of children (107/6769); Staphylococcus aureus and Streptococcus pneumoniae were most commonly identified.
CONCLUSIONS: Complications contribute substantially to the disease burden among children hospitalized with influenza, through intensive care requirements and prolonged hospitalization, highlighting the importance of primary prevention with influenza vaccination.

Entities:  

Keywords:  bacterial infection; children; children, hospitalized; complications; influenza

Mesh:

Year:  2013        PMID: 23986545     DOI: 10.1093/infdis/jit473

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

1.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

2.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

3.  Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia.

Authors:  Ikwo K Oboho; Anna Bramley; Lyn Finelli; Alicia Fry; Krow Ampofo; Sandra R Arnold; Wesley H Self; Derek J Williams; D Mark Courtney; Yuwei Zhu; Evan J Anderson; Carlos G Grijalva; Jonathan A McCullers; Richard G Wunderink; Andrew T Pavia; Kathryn M Edwards; Seema Jain
Journal:  Open Forum Infect Dis       Date:  2016-12-27       Impact factor: 3.835

4.  Predictors of Influenza Diagnosis Among Patients With Laboratory-Confirmed Influenza.

Authors:  Marc R Miller; Timothy R Peters; Cynthia K Suerken; Beverly M Snively; Katherine A Poehling
Journal:  J Infect Dis       Date:  2015-05-04       Impact factor: 5.226

5.  Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B Viruses.

Authors:  Louise A Carolan; Steve Rockman; Kathryn Borg; Teagan Guarnaccia; Patrick Reading; Jennifer Mosse; Anne Kelso; Ian Barr; Karen L Laurie
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

6.  Effects of bacterial and viral co-infections of mycoplasma pneumoniae pneumonia in children: analysis report from Beijing Children's Hospital between 2010 and 2014.

Authors:  Qing Song; Bao-Ping Xu; Kun-Ling Shen
Journal:  Int J Clin Exp Med       Date:  2015-09-15

7.  Detection of Multiple Respiratory Viruses Associated With Mortality and Severity of Illness in Children.

Authors:  Kyle J Rehder; Elizabeth A Wilson; Kanecia O Zimmerman; Coleen K Cunningham; David A Turner
Journal:  Pediatr Crit Care Med       Date:  2015-09       Impact factor: 3.624

8.  Contributions of Influenza Virus Hemagglutinin and Host Immune Responses Toward the Severity of Influenza Virus: Streptococcus pyogenes Superinfections.

Authors:  Joshua M Klonoski; Trevor Watson; Thomas E Bickett; Joshua M Svendsen; Tonia J Gau; Alexandra Britt; Jeff T Nelson; Evelyn H Schlenker; Michael S Chaussee; Agnieszka Rynda-Apple; Victor C Huber
Journal:  Viral Immunol       Date:  2018-06-05       Impact factor: 2.257

Review 9.  Acute otitis media with spontaneous tympanic membrane perforation.

Authors:  N Principi; P Marchisio; C Rosazza; C S Sciarrabba; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-27       Impact factor: 3.267

10.  Incidence, Morbidity, and Costs of Human Metapneumovirus Infection in Hospitalized Children.

Authors:  Carly R Davis; Chris Stockmann; Andrew T Pavia; Carrie L Byington; Anne J Blaschke; Adam L Hersh; Emily A Thorell; Kent Korgenski; Judy Daly; Krow Ampofo
Journal:  J Pediatric Infect Dis Soc       Date:  2015-05-20       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.